Post by
99942Apophis on Oct 23, 2023 9:15am
Health Canada
Today's approval by Health Canada was perhaps overlooked by many of us because we were so focused on the US FDA , however to me and everyone I can truly say we are beyond pleased with this news release. In a short while I believe we will also hear the same positive approval coming from the FDA, Today's news has removed the pins & needles from my anticipation, great news and a big thank you to all those at Theralase who made this happen.
Comment by
riverrrow on Oct 23, 2023 10:02am
As a follow up this is also a very good indication that Health Canada recognizes the safety aspects of Ruvidar and that multiple treatments have a good prospect of raising the CR.
Comment by
99942Apophis on Oct 23, 2023 10:12am
yes riverrrow you are correct, after reading it again I realize my error.
Comment by
CAinPlap on Oct 23, 2023 10:21am
My take on the trial amendment is that the original trial protocol called for 2 treatments. As some patients were chosing not to get the 2nd treatment, the trial was tainted as they were not following the original trial protocol. This fixes that.
Comment by
Longholder99 on Oct 23, 2023 10:22am
I agree. In giving no objection to additional treatments as required Health Canada has given the green light quietly AND has said it without saying it....that Ruvidar can and does remove cancerous cells from the bladder safely. Just sometimes you have to do it a few times and not necessarily on a date driven schedule. Very big news if you think about it.
Comment by
Rumpl3StiltSkin on Oct 23, 2023 10:31am
OK, so will the FDA do the same? :-)
Comment by
skys1 on Oct 23, 2023 2:46pm
This developement also means many patients getting additional treatments. additional treatments means more revenue and therefore more profits. TLT keeps getting more valuable to a prospective suitor.
Comment by
menoalittle on Oct 23, 2023 2:55pm
>> prospective suitor Can't say as I would object much to a takeover deal from Merck at this point. As long as it's not a cash deal. 10 shares of TLT for 1 of MRK? (would probably be quite the bargain from MRK's perspective...)
Comment by
Infinity on Oct 23, 2023 3:10pm
That would be dream come true proposal. Potentialy a perfect combination to supplement Ruvidar to their already approved Keytruda. Make Keytruda more effective..
Comment by
chry200030 on Oct 23, 2023 3:16pm
might be a bit too cheap. 5 for 1 would be about right..
Comment by
Oden6570 on Oct 23, 2023 4:19pm
And I will drink to that !
Comment by
99942Apophis on Oct 23, 2023 4:20pm
skys1, I would be very interested in seeing your calculations to support your $10 a share price. In the past my calculations were laid out for anyone to criticize or support, what PE ratio are you using? My lowest share price at the time was $20 however that was only for NMIBC in Canada & US.
Comment by
Paradise818 on Oct 23, 2023 2:56pm
How much will the patent for Ruvidar and updates be worth once approval received and we also start treating other cancers? Sherri is going to be one rich girl.
Comment by
skys1 on Oct 23, 2023 11:55am
I agree riverrow, this is a very positive news release and will provide an additional aspect to TLT in it's trial results. How some on this Board can create some negativity related to it makes no sense. It just confirms SF's opinion of the negativity on this board.